"Finasteride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.
Descriptor ID |
D018120
|
MeSH Number(s) |
D04.210.500.054.079.500 D04.210.500.925.100.250
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Finasteride".
Below are MeSH descriptors whose meaning is more specific than "Finasteride".
This graph shows the total number of publications written about "Finasteride" by people in this website by year, and whether "Finasteride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Finasteride" by people in Profiles.
-
Association between 5-alpha reductase inhibition and risk of hip fracture. JAMA. 2008 Oct 08; 300(14):1660-4.
-
A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997. J Urol. 2005 Jun; 173(6):2048-53.
-
Re: Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. J Urol. 2003 May; 169(5):1798-9.
-
The role of community-based longitudinal studies in evaluating treatment effects. Example: benign prostatic hyperplasia. Med Care. 1995 Apr; 33(4 Suppl):AS26-35.